NAUT
Nautilus Biotechnology Inc
1.40$
+4.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Nautilus Biotechnology Inc (NAUT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -238 | -9.7 | -14 | -39 | -46 | -52 | -59 | -51 | |
| – | 0.5 | 2.3 | 2.8 | 3.4 | 5.7 | 6.4 | 6.5 | |
| – | 0.1 | 0.4 | 7.9 | 10 | 12 | 13 | 6.8 | |
| – | -0.1 | 0.7 | 8.1 | 10 | – | – | – | |
| 1.3 | -0.5 | -1.4 | 0.0 | -0.8 | -3.2 | -5.5 | -3.6 | |
| 0.0 | 0.9 | 0.9 | 2.3 | 2.3 | 2.4 | 2.1 | 1.3 | |
| 1.2 | 4.1 | -25 | -139 | -26 | -44 | 66 | 35 | |
| – | – | 0.1 | – | – | – | – | – | |
| -1.2 | -0.9 | 154 | -8.0 | 0.2 | 0.3 | 0.5 | 0.2 | |
| 145,187 | 0.0 | 76 | 327 | 0.6 | 0.4 | 1.1 | 0.2 | |
| 1.2 | 0.6 | 37 | 149 | -71 | -95 | 8.2 | -15 | |
| -238 | -11 | -15 | -42 | -48 | -54 | -61 | -52 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.